On January 11, 2020, the Broad Institute, Verily Life Sciences, and Microsoft announced a strategic partnership to accelerate biomedical innovations
Continue Reading Microsoft Partners with Broad Institute and Verily to Expand Terra Platform for Biomedical Research
Earlier this week, Biogen and ViGeneron signed a global collaboration and licensing agreement to develop gene therapies for inherited eye
Continue Reading Biogen and ViGeneron to Collaborate on Ophthalmic Gene Therapy Development
The Italian pharmaceutical company Angelini Pharma announced on January 4, 2021, that it will acquire emerging Swiss biotech company
Continue Reading The New Exclusive European Licensee of Cenobamate: Angelini Pharma Acquires Emerging Swiss Biotech Company Arvelle Therapeutics
Cadent Therapeutics, a Cambridge, Massachusetts-based, privately held clinical stage biopharmaceutical company focused on the development of therapies for the
Continue Reading Cadent Therapeutics Acquired by Novartis for Up to $770 Million
AstraZeneca, the British-Swedish multinational pharmaceutical company currently collaborating with the University of Oxford on a COVID-19 vaccine, will purchase Alexion
Continue Reading As its COVID-19 Vaccine Nears Finalization, AstraZeneca Announces Deal to Buy Alexion for $39 Billion
Quick heads up, the World Economic Forum released a Special Report covering what it considers to the the top 10
Continue Reading World Economic Forum Releases Top 10 Emerging Technologies of 2020
As Pfizer and BioNTech announced this week that results of their COVID-19 vaccine have exceeded expectations, the technology behind the
Continue Reading Breaking Down Moderna’s COVID-19 Patent Pledge: Why Did They Do It?
At this point we have all heard how artificial intelligence (AI) will change the world, and many of us have
Continue Reading USPTO Report Shows Tremendous Growth in Patent Filings on Artificial Intelligence
On October 22, 2020, Boston-based Atea Pharmaceuticals, Inc. (“Atea”) announced an agreement with Roche for the exclusive rights to research,
Continue Reading Atea Pharmaceuticals Collaborates with Roche on Oral COVID-19 Therapeutic